Pan American Silver (PAAS) closed the last trading session at $24.20, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $31.23 indicates a 29.1% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $4.44. While the lowest estimate of $26 indicates a 7.4% increase from the current price level, the most optimistic analyst ...

Group 1 - Xperi (XPER) has shown a 7.3% increase in stock price over the past four weeks, with a mean price target of $18.25 indicating a potential upside of 134.3% [1] - The mean estimate includes four short-term price targets with a standard deviation of $8.02, suggesting variability in analyst predictions; the lowest estimate of $12 indicates a 54% increase, while the highest estimate suggests a 285.1% increase to $30 [2] - Analysts show strong agreement on XPER's ability to report better earnings than previously predicted, which supports the view of potential upside [4] Group 2 - The Zacks Consensus Estimate for XPER has increased by 46.2% over the past month, with no negative revisions, indicating positive earnings momentum [12] - XPER holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, which is a strong indicator of potential upside [13] - While consensus price targets may not be reliable for predicting exact stock gains, they can provide a directional guide for price movement [13]

Spyre Therapeutics (SYRE) closed the last trading session at $15.55, gaining 6.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $53.50 indicates a 244.1% upside potential.The mean estimate comprises 10 short-term price targets with a standard deviation of $16.36. While the lowest estimate of $21 indicates a 35.1% increase from the current price level, the most optimistic analyst ...

GeneDx Holdings Corp. (WGS) closed the last trading session at $70.02, gaining 4.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $92.86 indicates a 32.6% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $15.09. While the lowest estimate of $78 indicates an 11.4% increase from the current price level, the most optimistic ana ...

Eastern Bankshares, Inc. (EBC) closed the last trading session at $14.78, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $19.25 indicates a 30.2% upside potential.The average comprises four short-term price targets ranging from a low of $16 to a high of $23, with a standard deviation of $2.99. While the lowest estimate indicates an increase of 8.3% from the current pr ...

Market players were eager to push the start button on Nintendo (NTDOY 5.13%) stock as the trading week drew to a close. Shares of the storied Japanese video game company finished Friday up by more than 5% thanks in no small part to an analyst's price-target increase. That rise was in contrast to the S&P 500's dip of 0.4%.A bull gets more bullishBefore market open that day, JPMorgan Chase's Junko Yamamura lifted her fair value assessment on Nintendo's Japan-listed stock to 15,300 yen ($106.52) per share, up ...

Shares of Impinj (PI) have gained 52.5% over the past four weeks to close the last trading session at $117.52, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $149.50 indicates a potential upside of 27.2%.The mean estimate comprises eight short-term price targets with a standard deviation of $55.04. While the lowest estimate of $100 indicates a 14.9% decline from the current pri ...

Core Viewpoint - Provident Financial (PFS) shows potential for significant upside, with a mean price target of $21.50 indicating a 28.1% increase from the current price of $16.78 [1] Price Targets and Analyst Consensus - The average price targets from analysts range from a low of $18 to a high of $24, with a standard deviation of $2.17, suggesting a moderate agreement among analysts [2] - The lowest estimate indicates a 7.3% increase, while the highest suggests a 43% upside [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about PFS's earnings prospects, with a strong consensus on higher EPS estimates, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 0.3%, with two estimates moving higher and no negative revisions [12] - PFS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]

Shares of Centerra Gold Inc. (CGAU) have gained 2.8% over the past four weeks to close the last trading session at $6.88, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $8.76 indicates a potential upside of 27.3%.The average comprises 11 short-term price targets ranging from a low of $6.50 to a high of $11, with a standard deviation of $1.19. While the lowest estimate indicates ...

Core Viewpoint - North American Construction (NOA) has shown a significant price increase of 11.1% over the past four weeks, with a mean price target of $25.70 indicating a potential upside of 51.1% from its current price of $17.01 [1] Price Targets and Analyst Consensus - The average price target for NOA ranges from a low of $19.46 to a high of $31.68, with a standard deviation of $3.99, suggesting a variability in analyst estimates [2] - The lowest estimate indicates a 14.4% increase, while the highest suggests an 86.2% upside [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Optimism - Analysts are optimistic about NOA's earnings prospects, as indicated by a trend of upward revisions in earnings estimates [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 1.3%, with one estimate moving higher and no negative revisions [12] - NOA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after, they can mislead investors, as empirical research shows they rarely indicate actual stock price movements [7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8] - Investors should treat price targets with skepticism and not rely solely on them for investment decisions [10]